The Current and Future Roles of Precision Oncology in Advanced Breast Cancer

被引:1
作者
Jacene, Heather [1 ]
Dietsche, Eric [2 ]
Specht, Jennifer [3 ]
机构
[1] Dana Farber Brigham Canc Ctr, Imaging Radiol, Boston, MA 01757 USA
[2] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Radiol, Providence, RI USA
[3] Univ Washington, Fred Hutch Canc Ctr, Dept Med, Div Hematol & Oncol & Clin Res, Seattle, WA USA
关键词
breast cancer; molecular imaging; precision; FDG; FES; PET; INVASIVE LOBULAR CARCINOMA; NEOADJUVANT CHEMOTHERAPY; F-18-FDG PET/CT; PROGESTERONE-RECEPTOR; PATHOLOGICAL RESPONSE; DOUBLE-BLIND; FDG-PET/CT; OPEN-LABEL; PHASE-II; TRASTUZUMAB;
D O I
10.2967/jnumed.122.264882
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Breast cancer is a common but heterogeneous disease characterized by several biologic features, including tumor grade, hormone receptor status, human epidermal growth factor receptor 2 status, and gene expression assays. These biologic and genomic features drive treatment decisions. In the advanced disease setting, inter- and intrapatient tumor heterogeneity is increasingly recognized as a challenge for optimizing treatment. Recent evidence and the recent approval of novel radiopharmaceuticals have increased recognition and acceptance of the potential of molecular imaging as a biomarker to impact and guide management decisions for advanced breast cancer.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 79 条
[1]   68Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity A Head-to-Head Comparative Study [J].
Alcin, Goksel ;
Arslan, Esra ;
Aksoy, Tamer ;
Cin, Merve ;
Fenercioglu, Ozge Erol ;
Beyhan, Ediz ;
Ergul, Nurhan ;
Cermik, Tevfik Fikret .
CLINICAL NUCLEAR MEDICINE, 2023, 48 (09) :E420-E430
[2]  
Amin AB, 2018, AJCC Cancer Staging Manual, V8th, P589
[3]   Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Backhaus, Philipp ;
Burg, Matthias C. ;
Asmus, Inga ;
Pixberg, Michaela ;
Buethers, Florian ;
Breyholz, Hans-Joerg ;
Yeh, Randy ;
Weigel, Stefanie B. ;
Stichling, Patricia ;
Heindel, Walter ;
Bobe, Stefanie ;
Barth, Peter ;
Tio, Joke ;
Schaefers, Michael .
JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (05) :717-723
[4]   Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer [J].
Bardia, A. ;
Hurvitz, S. A. ;
Tolaney, S. M. ;
Loirat, D. ;
Punie, K. ;
Oliveira, M. ;
Brufsky, A. ;
Sardesai, S. D. ;
Kalinsky, K. ;
Zelnak, A. B. ;
Weaver, R. ;
Traina, T. ;
Dalenc, F. ;
Aftimos, P. ;
Lynce, F. ;
Diab, S. ;
Cortes, J. ;
O'Shaughnessy, J. ;
Dieras, V ;
Ferrario, C. ;
Schmid, P. ;
Carey, L. A. ;
Gianni, L. ;
Piccart, M. J. ;
Loibl, S. ;
Goldenberg, D. M. ;
Hong, Q. ;
Olivo, M. S. ;
Itri, L. M. ;
Rugo, H. S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16) :1529-1541
[5]   Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer [J].
Baselga, Jose ;
Cortes, Javier ;
Kim, Sung-Bae ;
Im, Seock-Ah ;
Hegg, Roberto ;
Im, Young-Hyuck ;
Roman, Laslo ;
Pedrini, Jose Luiz ;
Pienkowski, Tadeusz ;
Knott, Adam ;
Clark, Emma ;
Benyunes, Mark C. ;
Ross, Graham ;
Swain, Sandra M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) :109-119
[6]   Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial [J].
Bidard, Francois-Clement ;
Kaklamani, Virginia G. ;
Neven, Patrick ;
Streich, Guillermo ;
Montero, Alberto J. ;
Forget, Frederic ;
Mouret-Reynier, Marie-Ange ;
Sohn, Joo Hyuk ;
Taylor, Donatienne ;
Harnden, Kathleen K. ;
Khong, Hung ;
Kocsis, Judit ;
Dalenc, Florence ;
Dillon, Patrick M. ;
Babu, Sunil ;
Waters, Simon ;
Deleu, Ines ;
Saenz, Jose A. Garcia ;
Bria, Emilio ;
Cazzaniga, Marina ;
Lu, Janice ;
Aftimos, Philippe ;
Cortes, Javier ;
Liu, Shubin ;
Tonini, Giulia ;
Laurent, Dirk ;
Habboubi, Nassir ;
Conlan, Maureen G. ;
Bardia, Aditya .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) :3246-+
[7]   Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study [J].
Boers, Jorianne ;
Loudini, Naila ;
Brunsch, Celina L. ;
Koza, Sylvia A. ;
de Vries, Erik F. J. ;
Glaudemans, Andor W. J. M. ;
Hospers, Geke A. P. ;
Schroder, Carolina P. .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (09) :1214-1220
[8]   Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Cardoso, F. ;
Senkus-Konefka, E. ;
Fallowfield, L. ;
Costa, A. ;
Castiglione, M. .
ANNALS OF ONCOLOGY, 2010, 21 :v15-v19
[9]   Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer [J].
Connolly, Roisin M. ;
Leal, Jeffrey P. ;
Solnes, Lilja ;
Huang, Chiung-Yu ;
Carpenter, Ashley ;
Gaffney, Katy ;
Abramson, Vandana ;
Carey, Lisa A. ;
Liu, Minetta C. ;
Rimawi, Mothaffar ;
Specht, Jennifer ;
Storniolo, Anna Maria ;
Valero, Vicente ;
Vaklavas, Christos ;
Krop, Ian E. ;
Winer, Eric P. ;
Camp, Melissa ;
Miller, Robert S. ;
Wolff, Antonio C. ;
Cimino-Mathews, Ashley ;
Park, Ben H. ;
Wahl, Richard L. ;
Stearns, Vered .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (20) :2247-+
[10]   Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].
Cortazar, Patricia ;
Zhang, Lijun ;
Untch, Michael ;
Mehta, Keyur ;
Costantino, Joseph P. ;
Wolmark, Norman ;
Bonnefoi, Herve ;
Cameron, David ;
Gianni, Luca ;
Valagussa, Pinuccia ;
Swain, Sandra M. ;
Prowell, Tatiana ;
Loibl, Sibylle ;
Wickerham, D. Lawrence ;
Bogaerts, Jan ;
Baselga, Jose ;
Perou, Charles ;
Blumenthal, Gideon ;
Blohmer, Jens ;
Mamounas, Eleftherios P. ;
Bergh, Jonas ;
Semiglazov, Vladimir ;
Justice, Robert ;
Eidtmann, Holger ;
Paik, Soonmyung ;
Piccart, Martine ;
Sridhara, Rajeshwari ;
Fasching, Peter A. ;
Slaets, Leen ;
Tang, Shenghui ;
Gerber, Bernd ;
Geyer, Charles E., Jr. ;
Pazdur, Richard ;
Ditsch, Nina ;
Rastogi, Priya ;
Eiermann, Wolfgang ;
von Minckwitz, Gunter .
LANCET, 2014, 384 (9938) :164-172